SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-19-000027
Filing Date
2019-02-12
Accepted
2019-02-12 16:31:07
Documents
41
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED DECEMBER 31, 2018 bivi-20181231_10q.htm 10-Q 293953
2 EXHIBIT 31.1 bivi-20181231_10qex31z1.htm EX-31.1 12628
3 EXHIBIT 31.2 bivi-20181231_10qex31z2.htm EX-31.2 13494
4 EXHIBIT 32.1 bivi-20181231_10qex32z1.htm EX-32.1 5461
5 EXHIBIT 32.2 bivi-20181231_10qex32z2.htm EX-32.2 5922
  Complete submission text file 0001520138-19-000027.txt   1725944

Data Files

Seq Description Document Type Size
6 XBRL LABEL FILE bivi-20181231_lab.xml EX-101.LAB 173404
7 XBRL PRESENTATION FILE bivi-20181231_pre.xml EX-101.PRE 125659
8 XBRL SCHEMA FILE bivi-20181231.xsd EX-101.SCH 23126
9 XBRL INSTANCE FILE bivi-20181231.xml EX-101.INS 252980
10 XBRL CALCULATION FILE bivi-20181231_cal.xml EX-101.CAL 29577
11 XBRL DEFINITION FILE bivi-20181231_def.xml EX-101.DEF 61598
Mailing Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025
Business Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 19591310
SIC: 2834 Pharmaceutical Preparations